Bonaventura Clotet to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Bonaventura Clotet has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.464
-
Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice. Br J Clin Pharmacol. 2007 Jun; 63(6):715-21.
Score: 0.287
-
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. Lancet HIV. 2018 11; 5(11):e638-e646.
Score: 0.162
-
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin. 2004 Dec; 22(10):564-642.
Score: 0.015